This proposal focuses on signal transduction events that mediate adipocyte development. Adipose tissue is subject to complex modulation by growth factors at the level of adipocyte precursor cell proliferation and differentiation. Insulin-like growth factor-I (IGF-I) stimulates growth of proliferating preadipocytes, but upon growth arrest, IGF-I stimulates differentiation into adipocytes. Defining the signaling pathways mediating this dual role of IGF-I is the subject of our proposal. In our preliminary studies, we have made novel observations associating the change in function with a change in IGF-I signaling. IGF-I's mitogenic effect is dependent on activation of the mitogen-activated protein kinases (MAPKs), ERK1 and ERK2. ERK activation, in turn, occurs via IGF-I receptor (IGFR)mediated phosphorylation of the adaptor protein Shc, and not IRS-1. We tested the hypothesis that Src family kinases (SFKs) mediate IGF-I mitogenic signaling. The Src family kinase inhibitor, PP 1, blocks IGF-I-mediated Shc and MAPK activation in proliferating 3T3-L 1 cells. Transient transfection of a dominant-negative, kinase-dead Src mutant inhibits IGF-I activation of MAPKs. IGF-I stimulates the activities of SFK members c-Src and Fyn in proliferating 3T3-Ll cells. Although SFKs are known to modulate IGFR-mediated cell transformation and mitogenic signaling by other growth factors, our studies are novel in identifying a role for SFKs in IGF-I-mediated preadipocyte growth. The present proposal is aimed at defining the role of SFKs in IGF-I-mediated preadipocyte proliferation. We hypothesize that IGF-I signaling through Src is uncoupled when preadipocytes undergo growth arrest, thus allowing IGF-I to act as a differentiation-inducing factor. We will use two established models for adipogenesis, the 3T3-L1 cell line and primary cultures of mouse preadipocytes, to achieve the following specific aims: 1. Characterize Src-mediated mitogenic pathway downstream from IGF-I, and determine if the role of Src is specific to IGF-I. 2. Elucidate the mechanism associated with growth arrest that uncouples Src kinases from IGF-I mitogenic signaling. 3. Determine if loss of Src activation is required for IGF-I-mediated 313-Li differentiation, and what role SFKs play in pathways that mediate the differentiation effects of IGF-I. These studies will better define IGF-I signaling pathways that mediate adipogenesis, and may identify targets for the modulation of obesity.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Endocrinology Study Section (END)
Program Officer
Haft, Carol R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Rhode Island Hospital
United States
Zip Code
Neacsu, Otilia; Cleveland, Kelly; Xu, Haiyan et al. (2013) IGF-I attenuates FFA-induced activation of JNK1 phosphorylation and TNF? expression in human subcutaneous preadipocytes. Obesity (Silver Spring) 21:1843-9
Cleveland-Donovan, Kelly; Maile, Laura A; Tsiaras, William G et al. (2010) IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects. Endocrinology 151:3752-63
Harrington, Molly; Pond-Tor, Sunthorn; Boney, Charlotte M (2007) Role of epidermal growth factor and ErbB2 receptors in 3T3-L1 adipogenesis. Obesity (Silver Spring) 15:563-71
Boney, Charlotte M; Verma, Anila; Tucker, Richard et al. (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115:e290-6
Sekimoto, Hiroko; Eipper-Mains, Jodi; Pond-Tor, Sunthorn et al. (2005) (alpha)v(beta)3 integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogen-activated protein kinase in 3T3-L1 cells. Mol Endocrinol 19:1859-67
Sekimoto, Hiroko; Boney, Charlotte M (2003) C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation. Endocrinology 144:2546-52